SEVERE REVERSIBLE RENAL-FAILURE WITH BEZAFIBRATE

被引：16

作者：

LIPKIN, GW

TOMSON, CRV

机构：

来源：

LANCET | 1993年 / 341卷 / 8841期

关键词：

D O I：

10.1016/0140-6736(93)90170-L

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：371 / 371

页数：1

共 5 条

[1] NEW DRUGS - LIPID LOWERING DRUGS [J].

OCONNOR, P ;

FEELY, J ;

SHEPHERD, J .

BMJ-BRITISH MEDICAL JOURNAL, 1990, 300 (6725) :667-672

[2] ADVERSE EFFECT OF CYCLOSPORIN ON PLASMA-CHOLESTEROL IN RENAL-TRANSPLANT RECIPIENTS [J].

RAINE, AEG ;

CARTER, R ;

MANN, JI ;

MORRIS, PJ .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1988, 3 (04) :458-463

[3] IMMUNOSUPPRESSIVE THERAPY AND LIPOPROTEIN ABNORMALITIES AFTER CARDIAC TRANSPLANTATION [J].

STAMLER, JS ;

VAUGHAN, DE ;

LOSCALZO, J .

AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (04) :389-391

[4] LIPID ABNORMALITIES IN CYCLOSPORINE-PREDNISONE-TREATED RENAL-TRANSPLANT RECIPIENTS [J].

VATHSALA, A ;

WEINBERG, RB ;

SCHOENBERG, L ;

GREVEL, J ;

GOLDSTEIN, RA ;

VANBUREN, CT ;

LEWIS, RM ;

KAHAN, BD .

TRANSPLANTATION, 1989, 48 (01) :37-43

[5] THE SHORT-TERM EFFECTS OF BEZAFIBRATE ON THE HYPERTRIGLYCERIDEMIA OF MODERATE TO SEVERE UREMIA [J].

WILLIAMS, AJ ;

BAKER, F ;

WALLS, J .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (03) :361-367

← 1 →